• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RadNet Earnings: What To Look For From RDNT

By: StockStory
November 07, 2025 at 22:00 PM EST

RDNT Cover Image

Diagnostic imaging company RadNet (NASDAQ: RDNT) will be announcing earnings results next tomorrow afternoon. Here’s what to expect.

RadNet beat analysts’ revenue expectations by 1.6% last quarter, reporting revenues of $498.2 million, up 8.4% year on year. It was an exceptional quarter for the company, with a beat of analysts’ EPS estimates and an impressive beat of analysts’ same-store sales estimates.

Is RadNet a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting RadNet’s revenue to grow 6.7% year on year to $491.9 million, slowing from the 14.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.23 per share.

RadNet Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. RadNet has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 3.6% on average.

Looking at RadNet’s peers in the testing & diagnostics services segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Guardant Health delivered year-on-year revenue growth of 38.5%, beating analysts’ expectations by 12.6%, and Quest reported revenues up 13.2%, topping estimates by 3.3%. Guardant Health traded up 27.9% following the results while Quest was down 4.9%.

Read our full analysis of Guardant Health’s results here and Quest’s results here.

Investors in the testing & diagnostics services segment have had steady hands going into earnings, with share prices up 1.2% on average over the last month. RadNet is up 13.8% during the same time and is heading into earnings with an average analyst price target of $80.57 (compared to the current share price of $82.89).

P.S. In tech investing, "Gorillas" are the rare companies that dominate their markets—like Microsoft and Apple did decades ago. Today, the next Gorilla is emerging in AI-powered enterprise software. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

More News

View More
OpenAI's Restructuring Sets up What Could Be the Biggest IPO Ever
November 07, 2025
Via MarketBeat
Topics Initial Public Offering
Tickers AAPL AMZN AVGO BABA BKNG CRM
2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
November 07, 2025
Via MarketBeat
Tickers AAPL GM MP USAR
CrowdStrike Partners With CoreWeave But Investors Sell the News
November 07, 2025
Via MarketBeat
Tickers CRWD CRWV NVDA PLTR
Amprius Technologies Signals Electrifying Growth in 2026
November 07, 2025
Via MarketBeat
Tickers AMPX
Dave Stock: 180% Gain + Q3 Beat = Breakout Setup?
November 07, 2025
Via MarketBeat
Tickers DAVE

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap